This inventor holds 2 USPTO granted patents and 4 published patent applications and 4 EPO patents. Top assignee: Ipsen Biopharm Limited. Active years: 2024-2026.
Company Filing History:
Years Active: 2024-2026
Title: Mikhail Kalinichev: Innovator in Cancer Pain Management
Introduction
Mikhail Kalinichev is a notable inventor based in Wrexham, GB. He has made significant contributions to the field of medical science, particularly in the management of pain associated with bone cancer. His innovative approach has the potential to improve the quality of life for patients suffering from this debilitating condition.
Latest Patents
Mikhail Kalinichev holds a patent for a method titled "Suppression of bone cancer-induced allodynia." This method involves the administration of a therapeutically effective amount of a non-cytotoxic protease to patients suffering from bone cancer. This innovative technique aims to alleviate the pain and discomfort associated with bone cancer, showcasing Kalinichev's commitment to advancing medical treatments.
Career Highlights
Kalinichev is currently associated with Ipsen Biopharm Limited, where he continues to work on groundbreaking research and development in the pharmaceutical industry. His expertise and dedication to improving patient outcomes have made him a valuable asset to his team and the broader medical community.
Collaborations
Mikhail collaborates with Christine Favre, a fellow professional in the field. Their combined efforts contribute to the advancement of innovative solutions in cancer treatment.
Conclusion
Mikhail Kalinichev's work in developing methods for managing bone cancer-induced pain exemplifies the impact of innovation in healthcare. His contributions are paving the way for improved patient care and treatment options.